Does INTERFERON BETA-1B Cause Malignant neoplasm progression? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Malignant neoplasm progression have been filed in association with INTERFERON BETA-1B (Betaseron). This represents 0.1% of all adverse event reports for INTERFERON BETA-1B.
14
Reports of Malignant neoplasm progression with INTERFERON BETA-1B
0.1%
of all INTERFERON BETA-1B reports
1
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From INTERFERON BETA-1B?
Of the 14 reports, 1 (7.1%) resulted in death, 2 (14.3%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA-1B. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does INTERFERON BETA-1B Cause?
Multiple sclerosis relapse (1,229)
Influenza like illness (1,042)
Injection site pain (1,014)
Fatigue (783)
Drug ineffective (767)
Injection site erythema (724)
Injection site reaction (707)
Pain (597)
Headache (596)
Multiple sclerosis (589)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which INTERFERON BETA-1B Alternatives Have Lower Malignant neoplasm progression Risk?
INTERFERON BETA-1B vs INTERFERON GAMMA
INTERFERON BETA-1B vs INTERFERON GAMMA-1B
INTERFERON BETA-1B vs INVEGA
INTERFERON BETA-1B vs INVEGA SUSTENNA
INTERFERON BETA-1B vs INVESTIGATIONAL BIOSIMILARS